BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26037953)

  • 61. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro.
    Liang C; Jiang E; Yao J; Wang M; Chen S; Zhou Z; Zhai W; Ma Q; Feng S; Han M
    Hematology; 2018 Jan; 23(1):44-49. PubMed ID: 28581352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
    Lei J; Hasegawa H; Matsumoto T; Yasukawa M
    J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Immunocharacteristics of bone marrow mesenchymal stem cell].
    Hong ZF; Huang XJ; Yin ZY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):53-8. PubMed ID: 19203454
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN-
    Sivanathan KN; Rojas-Canales D; Grey ST; Gronthos S; Coates PT
    Stem Cells Int; 2017; 2017():1025820. PubMed ID: 28293262
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge.
    Chan WK; Lau AS; Li JC; Law HK; Lau YL; Chan GC
    Exp Hematol; 2008 Nov; 36(11):1545-55. PubMed ID: 18715686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.
    Zhang Z; Ding Y; Li W; Song B; Yang R
    Arthritis Res Ther; 2013 Oct; 15(5):R169. PubMed ID: 24286220
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunomodulatory effects of OX40Ig gene-modified adipose tissue-derived mesenchymal stem cells on rat kidney transplantation.
    Liu T; Zhang Y; Shen Z; Zou X; Chen X; Chen L; Wang Y
    Int J Mol Med; 2017 Jan; 39(1):144-152. PubMed ID: 27878248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype.
    Jin P; Zhao Y; Liu H; Chen J; Ren J; Jin J; Bedognetti D; Liu S; Wang E; Marincola F; Stroncek D
    Sci Rep; 2016 May; 6():26345. PubMed ID: 27211104
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.
    François M; Romieu-Mourez R; Li M; Galipeau J
    Mol Ther; 2012 Jan; 20(1):187-95. PubMed ID: 21934657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mesenchymal stem cells and adaptive immune responses.
    Cao W; Cao K; Cao J; Wang Y; Shi Y
    Immunol Lett; 2015 Dec; 168(2):147-53. PubMed ID: 26073566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro allogeneic immune cell response to mesenchymal stromal cells derived from human adipose in patients with rheumatoid arthritis.
    Usha Shalini P; Vidyasagar JV; Kona LK; Ponnana M; Chelluri LK
    Cell Immunol; 2017 Apr; 314():18-25. PubMed ID: 28108005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses.
    Chiossone L; Conte R; Spaggiari GM; Serra M; Romei C; Bellora F; Becchetti F; Andaloro A; Moretta L; Bottino C
    Stem Cells; 2016 Jul; 34(7):1909-21. PubMed ID: 27015881
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunodepletion and Hypoxia Preconditioning of Mouse Compact Bone Cells as a Novel Protocol to Isolate Highly Immunosuppressive Mesenchymal Stem Cells.
    Sivanathan KN; Gronthos S; Grey ST; Rojas-Canales D; Coates PT
    Stem Cells Dev; 2017 Apr; 26(7):512-527. PubMed ID: 27998209
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [IFN-γ stimulation enhances immunosuppressive capability of human umbilical cord mesenchymal stem cells].
    Liu XD; Liu D; Zang CB; Zhang HY; Ming Y; Chi LL; Shen BJ; Li D
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):605-11. PubMed ID: 24989262
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.
    Gray A; Maguire T; Schloss R; Yarmush ML
    Biotechnol Prog; 2015; 31(4):1058-70. PubMed ID: 25958832
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effect of mesenchymal stem cells on expression of CD69 in cord blood CIK/NK cells and quantity ratio of T regulatory cells in CIK/NK cell culture].
    Li Y; Wei J; Wu YF; Wang XP; Huang K; Lin YC; Huang SL; Fang JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1301-6. PubMed ID: 19840471
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High OCT4 Expression on T Lymphocyte Function].
    Guo XP; Chen YF; Chen P; Pan J; Ying PT; Zhao N; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1523-1530. PubMed ID: 37846711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.